1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) =
|
|
- Irene Malone
- 6 years ago
- Views:
Transcription
1 Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This exercise will require you to apply the knowledge you have learned about abstracting throughout this program. Refer to your coding and staging manuals to determine how this error should be corrected. Where pertinent, the abstracted text has been included to provide the documentation needed to select the most accurate code. GenEDITS Plus Report Detailed Edit Errors NCDB Submission Core Edits 2011 Cases 1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) = Abstracted Radiology: MRI Brain, 2/24/2011: 2cm lesion in the left frontal lobe consistent with malignancy. 2. RX Summ--Surgical Margins, Primary Site,ICDO3 E:Conflict among RX Summ--Surgical Margins, RX Summ--Surg Prim Site, E:Primary Site and Histologic Type ICD-O-3 RX Summ--Surgical Margins (866) = 9 _ RX Summ--Surg Prim Site (859) = 00 Primary Site (291) = C619 Histologic Type ICD-O-3 (301) = CS Tumor Size, Site, Histol ICDO3 E:Conflict among CS Tumor Size, Primary Site and Histologic Type ICD-O-3 CS Tumor Size (629) = 988 _ Primary Site (291) = C809 Histologic Type ICD-O-3 (301) =
2 RX Summ--Surg Prim Site, Primary Site, ICDO3 E:Conflict among RX Summ--Surg Prim Site, Primary Site, and Histologic Type ICD-O-3 RX Summ--Surg Prim Site (859) = 98 Primary Site (291) = C778 Histologic Type ICD-O-3 (301) = 9680 Abstracted Surgery: Biopsy of the lymph node only. 5. Race 1, Race 2, Race 3, Race 4, Race 5 E:If a race code = 99, all race codes must = 99 Race 1 (103) = 01 Race 2 (105) = RX Summ--Surg Prim Site, Primary Site, ICDO3 E:Conflict among RX Summ--Surg Prim Site, Primary Site, and Histologic Type ICD-O-3 RX Summ--Surg Prim Site (859) = 00 Primary Site (291) = C809 Histologic Type ICD-O-3 (301) = CS Extension, Primary Site, Behavior ICDO3 E:Conflict among Primary Site, Histologic Type ICD-O-3, Behavior Code E:ICD-O-3 and CS Extension Primary Site (291) = C711 Histologic Type ICD-O-3 (301) = 9401 Behavior Code ICD-O-3 (305) = 3 _ CS Extension (632) = 050 _ Type of Reporting Source (312) = 1 _ Abstracted Radiology: MRI Brain large tumor originating in the right frontal lobe. Tumor crosses the midline to involve the left frontal lobe. 8. CS Reg Nodes Ex, Pos, Site, Hist ICDO3, Report E:Regional Nodes Positive/Examined conflict Primary Site (291) = C259 Histologic Type ICD-O-3 (301) = 8140
3 Behavior Code ICD-O-3 (305) = 3 _ Regional Nodes Examined (541) = 00 Regional Nodes Positive (539) = 99 Type of Reporting Source (312) = 1 _ Abstracted Surgery: No surgery performed. No lymph nodes resected. 9. RX Summ--Surg Prim Site, Primary Site, ICDO3 E:Conflict among RX Summ--Surg Prim Site, Primary Site, and Histologic Type ICD-O-3 RX Summ--Surg Prim Site (859) = 41 Primary Site (291) = C511 Histologic Type ICD-O-3 (301) = 8070 Abstracted Surgery: Simple vulvectomy. 10. Edit: Behavior Code ICDO3, Seq Num--Central E: Behavior Code ICD-O-3 and Sequence Number--Central conflict Sequence Number--Central (281) [00] Primary Site (291) [C700] Histologic Type ICD-O-3 (301) [9530] Behavior Code ICD-O-3 (305) [0] _ Date of Diagnosis (283) [ ] 11. Edit: Behavior ICDO3, Summary Stage 2000 E: Behavior Code ICD-O-3 and SEER Summary Stage 2000 conflict Behavior Code ICD-O-3 (305) [2] _ SEER Summary Stage 2000 (528) [1] _ BLADDER, RT LATERAL WALL BX: HIGH GRADE UROTHELIAL CARCINOMA. TUMOR IS NOT INVASIVE. 12. Edit: CS Extension, CS Lymph Nodes, CS Mets at DX E: Conflict among CS Extension, Lymph Nodes, and Mets at DX Primary Site (291) [C673] Histologic Type ICD-O-3 (301) [8130] Behavior Code ICD-O-3 (305) [2] _ CS Extension (632) [010]
4 CS Lymph Nodes (635) [999] _ CS Mets at DX (638) [99] 13. Edit: CS Extension, Hematopoietic E: Conflict among Primary Site, Histologic Type ICD-O-3 and CS Extension Primary Site (291) [C420] Histologic Type ICD-O-3 (301) [9863] CS Extension (632) [999] _ 14. Edit: CS Extension, Primary Site, Behavior ICDO3 E: Conflict among Primary Site, Histologic Type ICD-O-3, Behavior Code ICD-O-3 and CS Extension Primary Site (291) [C209] Histologic Type ICD-O-3 (301) [8263] Behavior Code ICD-O-3 (305) [2] _ CS Extension (632) [000] _ IN SITU/INTRAMUCOSAL ADENOCARCINOMA ARISING IN A TUBULOVILLOUS ADENOMA. 15. Edit: Unknown Site, Laterality E: Unknown Site, Laterality must = 0 Primary Site (291) [C809] Laterality (295) [2] _ TUMOR IN THE LEFT LUNG C/W METASTASIS FROM AN UNKNOWN PRIMARY. 16. Edit: CS Extension, Primary Site, Histol ICDO3 E: Conflict among CS Extension, Primary Site and Histologic Type ICD-O-3 CS Extension (632) [000] _ Primary Site (291) [C182] Histologic Type ICD-O-3 (301) [9690] Behavior Code ICD-O-3 (305) [3] _ FOLLICULAR B CELL LYMPHOMA IN ASCENDING COLON. NO EVIDENCE OF LYMPH NODE INVOLVEMENT.
5 17. Edit: CS Lymph Nodes, Primary Site, Histol ICDO3 E: Conflict among CS Lymph Nodes, Primary Site and Histologic Type ICD-O-3 CS Lymph Nodes (635) [000] _ Primary Site (291) [C779] Histologic Type ICD-O-3 (301) [9690] Behavior Code ICD-O-3 (305) [3] _ 18. Edit: CS Mets at DX, Primary Site, Histol ICDO3 E: Conflict among CS Mets at DX, Primary Site and Histologic Type ICD-O-3 CS Mets at DX (638) [00] Primary Site (291) [C779] Histologic Type ICD-O-3 (301) [9690] Behavior Code ICD-O-3 (305) [3] _ 19. Edit: CS Tumor Size, Primary Site, Histol ICDO3 E: Conflict among CS Tumor Size, Primary Site and Histologic Type ICD-O-3 CS Tumor Size (629) [999] _ Primary Site (291) [C779] Histologic Type ICD-O-3 (301) [9690] 20. Edit: CS Lymph Nodes, Primary Site, Histol ICDO3 E: Conflict among CS Lymph Nodes, Primary Site and Histologic Type ICD-O-3 CS Lymph Nodes (635) [000] _ Primary Site (291) [C751] Histologic Type ICD-O-3 (301) [8272] Behavior Code ICD-O-3 (305) [0] _ 21. Edit: CS Tumor Size, Primary Site, Histol ICDO3 E: Conflict among CS Tumor Size, Primary Site and Histologic Type ICD-O-3 CS Tumor Size (629) [999] _ Primary Site (291) [C421] Histologic Type ICD-O-3 (301) [9861] 22. Edit: Date of 1st Crs RX--COC, Date of DX E: Date of 1st Crs RX--COC must not precede Date of Diagnosis
6 Date of 1st Crs RX--COC (843) [ ] Date of Diagnosis (283) [ ] BONE SCAN-NEG, CT ABD/PELVIS-NEG 03/15/2011-TRUS W/BX, 04/01/2011-RADICAL RETROPUBIC PROSTATECTOMY 23. Edit: Laterality, Primary Site E: Laterality must be provided for specified paired organs/sites Laterality (295) [0] _ Primary Site (291) [C310] Date of Diagnosis (283) [ ] 11/15/2011 PET/CT SHOWS R MAXILLARY SINUS TUMOR W/ OSSEOUS EROSION & SOFT TISSUE EXTENSION. 10/29/2011 O/S S BX R MAXILLARY SINUS-MD KERATINIZING SCCA 24. Edit: Laterality, Primary Site E: Laterality must be provided for specified paired organs/sites Laterality (295) [0] _ Primary Site (291) [C700] Date of Diagnosis (283) [ ] 12/16/2011 MRI BRAIN REVEALED MENINGIOMA ADJACENT TO LEFT SIDE OF THE SELLA TURSICA 25. Edit: Primary Site, Morphology-Type,Beh ICDO3 E: Site & Morphology conflict - ICDO3 Primary Site (291) [C719] Histologic Type ICD-O-3 (301) [9530] Behavior Code ICD-O-3 (305) [0] _ Over-ride Site/Type (1128) [<BLANK>] _ 26. Edit: Surgery, Rad, Surg/Rad Seq E: Conflict among surgery items, Rad--Regional RX Modality, RX Summ--Surg/Rad Seq RX Summ--Surg Prim Site (859) [00] RX Summ--Scope Reg LN Sur (861) [1] _ RX Summ--Surg Oth Reg/Dis (862) [0] _ Rad--Regional RX Modality (909) [27]
7 RX Summ--Surg/Rad Seq (875) [0] _ 1/14/2011 ESOPHAGUS MASS BX 1/25/2011 RESX L NECK NODE 2/4/2011-3/26/ CGY 3D (6&15MV) FOLLOWED BY BOOST OF FRAC 27. Edit: Surgery, Rad, Surg/Rad Seq E: Conflict among surgery items, Rad--Regional RX Modality, RX Summ--Surg/Rad Seq RX Summ--Surg Prim Site (859) [00] RX Summ--Scope Reg LN Sur (861) [0] _ RX Summ--Surg Oth Reg/Dis (862) [0] _ Rad--Regional RX Modality (909) [24] RX Summ--Surg/Rad Seq (875) [3] _ 28. Edit: Primary Site, Morphology-Type,Beh ICDO3 E: Site & Morphology conflict - ICDO3 Primary Site (291) [C809] Histologic Type ICD-O-3 (301) [8046] Behavior Code ICD-O-3 (305) [3] _ Over-ride Site/Type (1128) [<BLANK>] _ Edit: Seq Num--Central, Prim Site, Morph ICDO3 E: Seq_num, Site, Morph conflict - ICDO3 Sequence Number--Central (281) [02] Over-ride Ill-define Site (1131) [<BLANK>] _ Primary Site (291) [C809] Histologic Type ICD-O-3 (301) [8046] 46 Y/O WF W/ HX BREAST CA NOW W/ HEADACHES AND VOMITING. 1/6/2011 CT BRAIN SHOWED 2CM R FRONTAL LOBE MASS. 1/21/2011 R BRAIN TUMOR RESECTION: METASTATIC POORLY DIFF NON SMALL CELL CA. WORK UP DID NOT REVEAL A PRIMARY SITE. THIS IS NOT RELATED TO THE PREVIOUS BREAST CANCER.
8 GenEDITS Plus Report Summary by Edit NCDB Submission Core Edits 2011 Cases Data File - C:\GenEdits\new11.txt Range Processed Metafile - C:\GenEDITSplus\metafiles\Call_for_Data_2011.rmf Date of Run - 3/18/2011 Edit Set 1 - NCDB Coordinated Core Edits Record Count Total Error Records Total Error Messages Total Warning Messages - 0 Edit - Errors Warnings Skips Age at Diagnosis (SEER AGEDX) Age, Primary Site, Morph ICDO3--Adult (SEER) Age, Primary Site, Morph ICDO3--Pediatric (NPCR) Behavior Code ICDO3, Seq Num--Central (SEER IF114) Behavior ICDO3, Site, Histology ICDO Behavior ICDO3, Summary Stage Birth Date Birth Date, Date of Diagnosis CS Extension, CS Lymph Nodes, CS Mets at DX CS Extension, CS Tumor Size, Site, Hist ICDO CS Extension, Hematopoietic CS Extension, Primary Site, Behavior ICDO CS Extension, Primary Site, Histol ICDO CS Items, Date of DX (Subm) CS Lymph Nodes, Primary Site, Histol ICDO CS Mets at DX, Primary Site, Histol ICDO CS Site-Specific Factor CS Site-Specific Factor CS Tumor Size, Primary Site, Histol ICDO Date of 1st Crs RX--COC, Date of DX Date of Init RX--SEER, Date of DX Diagnostic Confirm, Seq Num--Central (SEER IF23) Diagnostic Confirmation, Behavior ICDO3(SEER IF31) Diagnostic Confirmation, Histology ICDO3(SEER IF48) Laterality, Primary Site Laterality, Primary Site, Morph ICDO3 (SEER IF42) Lymphoma ICDO3, Site, Summ Stg Morphology--Type/Behavior ICDO3 (SEER MORPH) Obsolete Codes - CS Extension (SEER IF146) Obsolete Codes - CS Lymph Nodes (SEER IF147) Primary Site, Histology, Behav ICDO Primary Site, Morphology-Imposs ICDO3 (SEER IF38) Primary Site, Morphology-Type,Beh ICDO3(SEER IF25) RX Summ--Hormone (NPCR) RX Summ--Scope Reg LN Sur, Site, ICDO3 (SEER IF RX Summ--Surg Prim Site, Site, ICDO3 (SEER IF108) Seq Num--Central, Prim Site, Morph ICDO3(SEER IF Surgery, Rad, Surg/Rad Seq Unknown Site, Hist ICDO3, Summ Stg Unknown Site, Laterality (SEER IF138)
1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
More informationStandards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Eighth Edition. COC Collect. COC Transmit
10 Record Type R R NAACCR 20 Patient ID Number R R R Reporting Registry 30 Registry Type NAACCR 35 FIN Coding System S NAACCR 37 Reserved 00 40 Registry ID S R R NAACCR 50 NAACCR Record Version R R NAACCR
More informationPathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative
GATRA 2016 Breast Case Demographics Name: Autumn Leaf Sex: F Date of Birth: 3/26/75 SSN: 098765432 Race: African American Marital Status: Single Address: 3615 Burnt Hickory Trail, Helen, GA 37285, White
More informationASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry
ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data Item Name Data Item Number NPCR Collect Recommendation
More informationAPPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13)
APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13) New Required Item by ASCR R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data NPCR Collect
More informationRequirements for Abstracted Text
Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationNCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions
NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without
More informationEVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH
More informationQuiz. b. 4 High grade c. 9 Unknown
Quiz 1. 10/11/12 CT scan abdomen/pelvis: Metastatic liver disease with probable primary colon malignancy. 10/17/12 Colonoscopy with polypectomy: Adenocarcinoma of sigmoid colon measuring at least 6 mm
More informationAlternate Name Item # Length Source of Standard Column # Alternate Name Item # Length Source of Standard Column #
RESERVED 04 750 46 482-527 RESERVED 05 1180 50 705-754 RESERVED 06 1190 45 943-987 RESERVED 07 1300 50 1065-1114 RESERVED 08 1650 50 1244-1293 RESERVED 09 1740 50 1397-1446 RESERVED 10 1835 50 2415-2464
More informationACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:
More informationCANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume
More informationI.2 CNExT This section was software specific and deleted in 2008.
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION
More information2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010
2010 Cancer Data Collection Updates: Standards Volume II, Version 12 NAACCR 2009 2010 Webinar Series Introduction What s New for 2010 Record length and record layout New/changed data items Multiple Primary
More informationCase Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.
Case Scenario 1 3/8/13 H&P 68 YR W/M presents w/elevated PSA. Patient is a non-smoker, current alcohol use. Physical Exam: On digital rectal exam the sphincter tone is normal and there is a 1 cm nodule
More informationTake Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules
Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in
More information2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.
Slide 1 2007 New Data Items Data Due in: Days In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules. Slide 2 5 New Data Items Ambiguous Terminology
More informationNAACCR Webinar Series 1
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar
More informationSEER Summary Stage Still Here!
SEER Summary Stage Still Here! CCRA NORTHERN REGION STAGING SYMPOSIUM SEPTEMBER 20, 2017 SEER Summary Stage Timeframe: includes all information available through completion of surgery(ies) in the first
More informationQUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX
QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX MP/H Quiz 1. A patient presented with a prior history of squamous cell carcinoma of the base of the tongue. The malignancy was originally diagnosed
More informationQUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX
QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX MP/H Quiz 1. A patient presented with a prior history of squamous cell carcinoma of the base of the tongue. The malignancy was originally diagnosed
More informationKyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System
Kyle L. Ziegler, CTR California Cancer Registry U.C. Davis Health System Overview New Data Items Reportability Clarifications New Coding Rules Grade ICD-O-3 Changes Collaborative Stage v0205 2 New Data
More informationDATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases
More informationQ&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1
Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1
More informationNPCR CLINICAL EDIT CHECKS
NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t
More informationProstate Overview Quiz
Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the
More informationLung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.
Lung Case Scenario 1 A 54 year white male presents with a recent abnormal CT of the chest. The patient has a history of melanoma, kidney, and prostate cancers. 10/24/13 Chest X-ray: 2.9 cm mass like density
More informationCase Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma
Case Scenario 1 History A 52 year old male with a 20 pack year smoking history presented with about a 6 month history of persistent hoarseness. The patient had a squamous cell carcinoma of the lip removed
More informationCase Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
More informationCase Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue
Case Scenario 1 Oncology Consult: Patient is a 51-year-old male with history of T4N3 squamous cell carcinoma of tonsil status post concurrent chemoradiation finished in October two years ago. He was hospitalized
More informationQUICK-START GUIDE NCDB Participant Use File (NCDB PUF)
QUICK-START GUIDE 2015 NCDB Participant Use File (NCDB PUF) The data included in this zipped file are provided in a flat text file format, and should be read with software such as SAS, SPSS (PASW), STATA,
More informationAJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?
AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer
More informationFINALIZED SEER SINQ S MAY 2012
FINALIZED SEER SINQ S MAY 2012 : 20120039 Primary site/heme & Lymphoid Neoplasms: What site do I code this to and what rule applies? How did you arrive at this? Please advise. See discussion. Patient with
More information11/21/13 CEA: 1.7 WNL
Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.
More information7/29/ Grade Coding Instructions ICD-O-3 Updates. Outline. Introduction to Coding Grade for 2014+
2014 Grade Coding Instructions ICD-O-3 Updates 1 I M P L E M E N T A T I O N T I M E L I N E ( S ) 2 0 1 4 F C D S D A M A P P E N D I X H A N D O U T S F C D S A N N U A L C O N F E R E N C E O R L A
More informationFCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data
FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data 2011 FCDS Educational Webcast Series Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR August 18, 2011 CDC-NPCR
More informationNew Visions in PET: Surgical Decision Making and PET/CT
New Visions in PET: Surgical Decision Making and PET/CT Stanley J. Goldsmith, MD Director, Nuclear Medicine Professor, Radiology & Medicine New York Presbyterian Hospital- Weill Cornell Medical Center
More informationCollaborative Staging
Slide 1 Collaborative Staging Site-Specific Instructions Prostate 1 In this presentation, we are going to take a closer look at the collaborative staging data items for the prostate primary site. Because
More informationFINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma
Case Scenario 1 HNP: A 70 year old white male presents with dysphagia. The patient is a current smoker, current user of alcohol and is HPV positive. A CT of the Neck showed mass in the left pyriform sinus.
More information1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.
History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationCase Scenario year-old white male presented to personal physician with dyspepsia with reflux.
Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately
More informationCase Scenario #1 Larynx
Case Scenario #1 Larynx 56 year old white female who presented with a 2 month history of hoarseness treated with antibiotics, but with no improvement. In the last 3 weeks, she has had a 15 lb weight loss,
More informationMCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR
MCR: MANAGEMENT OF 2018 CHANGES By: Maricarmen Traverso-Ortiz MPH, CGG, CTR LEARNING OBJECTIVES Discuss a summary of the new changes for 2018 Overview of how the Maryland Cancer Registry is managing and
More informationBoot Camp Case Scenarios
Boot Camp Case Scenarios Case Scenario 1 Patient is a 69-year-old white female. She presents with dyspnea on exertion, cough, and right rib pain. Patient is a smoker. 9/21/12 CT Chest FINDINGS: There is
More informationDonna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry
Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry April 2015 2015 Data Changes New Data Items Revised Data Items ICD-0-3 Reportability Change New ICDO Terms and Codes SEER
More informationIcd 10 code lung ca with mets to bone
Icd 10 code lung ca with mets to bone 2018 ICD-10 -CM Diagnosis Code C79.9.. C79.9 is a billable/specific ICD - 10 -CM code that can be used to indicate a diagnosis. Metastasis from malignant tumor of
More informationWHI Extension Appendix A, Form Report of Cancer Outcome (Ver. 8.2) Page 1
WHI Extension Appendix A, Form 130 - Report of Cancer Outcome (Ver. 8.2) Page 1 FORM: 130 - REPORT OF CANCER OUTCOME Version: 8.2 October 30, 2008 Description: When used: Purpose: 4-page form filled out
More informationVULVAR CARCINOMA. Page 1 of 5
VULVAR CARCINOMA EXAMPLE OF A VULVAR CARCINOMA USING PROPOSED TEMPLATE Case: Invasive squamous cell carcinoma arising in D-VIN Tumor in left labia major Left partial vaginectomy and sentinel lymph node
More informationLung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.
Lung NAACCR 2018 2019 WEBINAR SERIES 1 Q&A Please submit all questions concerning the webinar content through the Q&A panel. If you have participants watching this webinar at your site, please collect
More information10/24/2013. Continuing Education Hours. Presentation Outline. Rule Makers for National Data Collection. NPCR Program Standards,
2 013-2014 QUALITY IMPROVEMENT EDUCATION AND TRAINING NCRA CEU # 2013-114 Continuing Education Hours Date Event Sponsor 7/25/2013-7/26/2013 CEU Hrs FCDS Annual Conference, Sunrise, FL FCDS 8.25 2013-115
More information2018 New Grade Coding Rules It s a Good Thing!
2018 New Grade Coding Rules It s a Good Thing! Presented by Donna M. Hansen, CTR California Cancer Registry NAACCR Webinar May 1, 2018 & May 2, 2018 1 Acknowledgement Special Thanks To: Jennifer Ruhl,
More informationCase Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of
More informationPancreas Case Scenario #1
Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass
More informationPurpose. Encourage standard exchange of data between two key public health partners
Reporting Pathology Protocols for Colorectal Cancer 2005 NAACCR Conference: June 9, 2005 Ken Gerlach: CDC-NPCR Bette Smith: Ohio Cancer Registry Kathleen Davidson-Allen: PHI/California Cancer Registry
More informationWho What When Where Why. Case Finding 5 W s. NAACCR Webinar Series. Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC
Who What When Where Why Case Finding 5 W s NAACCR 2010-2011 Webinar Series Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC Agenda Case Finding Purpose Reportable lists Benign intracranial
More informationCase Scenario 1 History and Physical 3/15/13 Imaging Pathology
Case Scenario 1 History and Physical 3/15/13 The patient is an 84 year old white female who presented with an abnormal mammogram. The patient has a five year history of refractory anemia with ringed sideroblasts
More informationON-LINE REGISTRATION FCDS MONOGRAPH: 2004 ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FLORIDA ANNUAL CANCER REPORT: 2001 INCIDENCE
ON-LINE REGISTRATION FOR THE FCDS ANNUAL CONFERENCE, JULY 27-28, 2006, AND BROCHURE FCDS 2006 IMPLEMENTATION GUIDE FOR NAACCR VERSION 11 (REVISED 5/22/2006; ADDS NEW AND UPDATED EDITS FOR CASES RECEIVED
More informationVISUAL EDITING GUIDELINES March 2015 (revised June 2015)
March 2015 (revised June 2015) Developed for The Cancer Registry of Greater California under the direction of Winny Roshala, BA, CTR, Data Quality Control Director By the following contributing Authors:
More informationPancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)
Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones
More informationSummary NAACCR: What you need to know for 2017 Version 1.1. March ICD-O-3 Histologies. Reportability There are no reportability changes in 2017.
Summary NAACCR: What you need to know for 2017 Version 1.1. March 2017 ICD-O-3 Histologies 2.1 New Terms and Codes Not Yet Implemented ICD-O-3 s and terms effective for 2015 was postponed due to CSv2 software
More informationCommission on Cancer Updates
Commission on Cancer Updates OBJECTIVES PROVIDE CANCER REGISTRARS WITH INFORMATION ABOUT CURRENT COC 2018 CHANGES DISCUSS CHANGES RELATED TO CANCER REGISTRY DATA COLLECTION DISCUSS CHANGES RELATED TO CANCER
More informationPatient Identification Quiz
Patient Identification Quiz 1. A patient presents to your facility for the first time on 1/1/2009. At that time he has a history of lymphoma (9590/3), melanoma (8720/3) and meningioma (9530/0). These three
More informationCollecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009
Collecting Cancer Data: Prostate NAACCR 2008-2009 Webinar Series June 11, 2009 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview 2008-2009 NAACCR Webinar Series
More informationQ: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?
Q&A Session for Collecting Cancer Data: Ovary Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report? A: We reviewed both the
More informationCase Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationQ&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014
Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014 Q: If polycythemia ruba vera (PRV) or essential thrombocythemia (ET) is diagnosed by peripheral smear,
More informationDecember 2002 Monthly Memo
FLORIDA CANCER DATA SYSTEM December 2002 Monthly Memo CODING COMPLEX MORPHOLOGIC DIAGNOSES CODING COMPLEX BREAST HISTOLOGIES Apply these guidelines in priority order. Use the first guideline that applies
More informationNPCR s TNM Stage Calculator
NPCR s TNM Stage Calculator A Tool for Central Registry Quality Control and Consolidation Assistance NAACCR Annual Meeting June 16, 2016 Jennifer Seiffert Northrop Grumman Under contract to NPCR Joseph
More informationWeb Plus Instructions Radiation CCR
Web Plus Instructions Radiation CCR To begin entering Abstracts through Web Plus, you must first log into https://webplus.njscr.org/webplus/logonen.aspx with credentials that are provided to you once your
More information2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018
1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington
More informationFINALIZED SEER SINQ S NOVEMBER 2011
: 20110133 Multiple primaries/heme & Lymphoid Neoplasms: A patient was diagnosed 7/31/08 with DLBCL (9680/3) (biopsy left supraclav. node), stage IIIB. Treated with chemo. 10/14/10 biopsy right supraclav.
More information5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.
Bladder Case Scenario 1 History 5/23/16: A 52-year-old male, smoker was admitted to our hospital with a 3-month history of right pelvic pain, multiple episodes of gross hematuria, dysuria, and extreme
More informationRadiology Pathology Conference
Radiology Pathology Conference Sharlin Johnykutty,, MD, Cytopathology Fellow Sara Majewski, MD, Radiology Resident Friday, August 28, 2009 Presentation material is for education purposes only. All rights
More informationThis section allows identifying the facility, this information is important for data quality follow up. Source of Standard. Source of Standard
Data Dictionary Case Administration This section allows identifying the facility, this information is important for data quality follow up Facility Name This identifier is needed to evaluate This data
More informationQ: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.
Q&A Breast Webinar Q: One of my investigators is interested in knowing when Oncotype DX data collection was implemented. That data is collected in SSFs 22 and 23. I remember that the SSFs for breast were
More informationHistology Coding ANSWERS
Histology Coding ANSWERS 1.) Biopsy of a right thyroid nodule reveals papillary carcinoma. What is the ICD-O-3 code? a. 8050/3 - Papillary carcinoma b. 8260/3 - Papillary adenocarcinoma Rationale/comment:
More information12/10/2012 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS. Continuing Education Hours. Presentation Outline
IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS FCDS Webcast Series Steven Peace, BS, CTR December 13, 2012 2 Continuing Education Hours NCRA CEU # 2012-065 Date(s)
More information12/10/2012. Continuing Education Hours IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS
2 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS NCRA CEU # 2012-065 Continuing Education Hours Date(s) Event 7/26/2012-7/27/2012 2012-155 8/16/2012 Spons or FCDS
More informationManagement guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007
Management guideline for patients with differentiated thyroid Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Incidence (Srinagarind Hospital, 2005, both sex) Site (all) cases % 1. Liver 1178 27 2. Lung
More informationColon and Rectum: 2018 Solid Tumor Rules
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Colon and Rectum: 2018 Solid Tumor Rules 1 Colon and Rectum Solid Tumor Rules Separate sections for: Introduction Changes from 2007 MP/H rules Equivalent
More informationCODING PRIMARY SITE. Nadya Dimitrova
CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign
More informationProf. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.
Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Cancer is a potentially life-threatening disease,
More informationDefinition of Synoptic Reporting
Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are
More informationInstructions for Coding Grade for 2014+
Instructions for Coding for 2014+ GRADE, DIFFERENTIATION OR CELL INDICATOR Item Length: 1 NAACCR Item #: 440 NAACCR Name:, Differentiation for solid tumors (Codes 1, 2, 3, 4, 9) and Cell Indicator for
More informationCase Scenario 1: Breast
Case Scenario 1: Breast A 63 year old white female presents with a large mass in her left breast. 4/15/13 Mammogram/US: 1. Left breast mammographic and sonographic at 3:00 measuring 7.1 cm highly suggestive
More informationUsing PET/CT in Prostate Cancer
Using PET/CT in Prostate Cancer Legal Disclaimer These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More informationQ&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012
Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q: Will sticky notes be transferrable from the previous electronic version of CS to the updated version? A: It is our
More informationICD-O CODING Third Edition
Slide 1 ICD-O CODING Third Edition PART I An introduction to the ICD-O-3 Coding Manual This is part 1 of a 2-part slide presentation. Use the navigation buttons below this panel to advance the slides.
More information2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?
2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? SESSION 2 10/20/17 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session, the Q&A,
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationCase #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).
SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009
More informationExercise. Discharge Summary
Exercise Discharge Summary A 32-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was present
More informationThursday, August 16, :30 AM - 4:30 PM and Friday, August 17, :30 AM 12:00 PM Crowne Plaza 830 Phillips Lane Louisville, KY 40209
KCR newsletter March 2018 KCR 2018 Fall Workshop/Regional Meeting 2018 Tri-State Regional Cancer Registrars Meeting Presented by: Kentucky Cancer Registry, Indiana Cancer Consortium, and Ohio Cancer Incidence
More informationCollaborative Stage. Site-Specific Instructions - LUNG
Slide 1 Collaborative Stage Site-Specific Instructions - LUNG In this presentation, we are going to review the AJCC Cancer Staging criteria for the lung primary site. Slide 2 Reading Assignments As each
More informationAbstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:
Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 A 74 year old male with a history of GERD presents complaining of dysphagia. An esophagogastroduodenoscopy
More informationNeoplasms of the Prostate and Bladder
Neoplasms of the Prostate and Bladder 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 CDC & Florida DOH Attribution
More information